 |
26 Diseases |  |
7 Trials |
|
7 Trials |  |
4331 News |  |
| «12...39404142434445464748495051» |
- | Vascepa (icosapent ethyl) / Amarin
Journal: Cardiovascular Risk Reduction with Icosapent Ethyl. Reply. (Pubmed Central) - Apr 29, 2019
No abstract available
- | Eylea (aflibercept intravitreal) / Bayer, Regeneron, Vascepa (icosapent ethyl) / Amarin
Thanks for sharing. Would you be able to offer any perspective on overall participant reaction to the Vascepa/Reduce-It data? (Twitter) - Apr 25, 2019
- || Eylea (aflibercept intravitreal) / Bayer, Regeneron, Vascepa (icosapent ethyl) / Amarin
Cardiovascular Risk Reduction with Icosapent Ethyl | NEJM https://t.co/v4lnPdySlA (Twitter) - Apr 25, 2019
- |||| Vascepa (icosapent ethyl) / Amarin
Clinical: I agree with you Deepak. BTW are you giving Influenza vaccine (37% benefit for CVD) and pneumococcal vaccine (17% benefit for CVD)for all high-risk patients with documented benefits greater than statins, PCS9 I, ezetimibe, and Icosapent ethyl. (Twitter) - Apr 22, 2019
- || Vascepa (icosapent ethyl) / Amarin
Actually pg. 8 says "ethyl icosapentate". Likely Amarin partner Mochida's Epadel. So similar FDA allowed Amarin (vascepa) to use Epadel toxicity results. EPA/AA ratio vs western diet needs detail. EVAPORATE imaging trial (readout 2019) does that & will likely prove CHERRY. $AMRN (Twitter) - Apr 20, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: A good talk, however, the patients with TG <150mg% were only 10%. Do you think we can base our hypothesis of the pleitropic effect of Icosapent Ethyl upon such small numbers in the group? Was it a prespecified subgroup? (Twitter) - Apr 19, 2019
- |||||| Vascepa (icosapent ethyl) / Amarin
Video: Love how quickly they are incorporating new American Diabetes Association Standard of Care update re: icosapent ethyl (Vascepa) into CME as seen in this quiz question (pic). Full CME video hosted by .@DLBHATTMD and released today (4/18/19) at link. $AMRN https://t.co/ibKHs1Y5ov (Twitter) - Apr 19, 2019
- |||| Vascepa (icosapent ethyl) / Amarin
Clinical: Depends on geographic location, too when it comes to payors. For example, BCBS of Michigan made Vascepa preferred in Jan for their clinical and custom drug lists and that may yet go nationwide (BCBS) after the recent ADA SOC update to include icosapent ethyl but a slow process. (Twitter) - Apr 19, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: Currently following REDUCE-IT inclusion criteria (TG > 135)... anxiously awaiting a trial by @DLBHATTMD looking at post MI pts, regardless of TG, w addition of vascepa (Twitter) - Apr 18, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical, Clinical guideline: "Further evaluation of RCTs published after 2018 guidelines, such as RCT regarding icosapent ethyl, would be a high priority.." JAMA Cardiology Clinical Guidelines Synopsis of AHA/ACC/Multisociety Guideline on Management of Blood Cholesterol 4/17/2019 https://t.co/7LAMRwxNun (Twitter) - Apr 18, 2019
- |||| Vascepa (icosapent ethyl) / Amarin
Grand rounds: ICYMI: Full house today for Medicine Grand Rounds! @DLBHATTMD, former @CCFcards fellow, reviews the results of icosapent ethyl in REDUCE-IT Trial. A few summary slides below! @abbyCCim @medpedshosp @parthparikh90 @erikahuttce (Twitter) - Apr 18, 2019
- || Vascepa (icosapent ethyl) / Amarin
So you're talking about Omega 3 supplements, not Vascepa. Correct? (Twitter) - Apr 17, 2019
- || Vascepa (icosapent ethyl) / Amarin
Reducing residual cardiovascular risk with Icosapent ethyl - REDUCE-IT study by @DLBHATTMD and associates. https://t.co/5DBdI2mJK1 #CardioEd #MedEd #medtwitter #cardiotwitter #FOAMed #NEETSS #NEETSS2019 #ReduceIt (Twitter) - Apr 14, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: @avolgman if don't mind sharing, I would be curious what percent of your statin treated patients you are prescribing Vascepa to. After the ADA included in standards of care for statin-treated patients with TGs > 135, I would think the percentage would be high? TIA. (Twitter) - Apr 12, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
This was from October of 2018. Look at lower left of photo. $956 for a 90 day supply of Vascepa, my co pay was $9 (Twitter) - Apr 11, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Pricing, Reimbursement: #Amarin has a discount program for #Vascepa that reduces price or co-pay. For many, the insurance co-pay is $9 for 90 days. Even at full price it should only be about $300. Try here: https://t.co/LRY1suOT0f (Twitter) - Apr 10, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical, Pricing: .@DLBHATTMD Not sure what happened in last 2-4 weeks, but I cannot get Vascepa for my patients at an affordable price.. running $400-600/month.. unreasonable. (Twitter) - Apr 10, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
FDA event: That’s great! Where’s the FDA in deciding Accelerated Approval for Amarin’s Vascepa? Thanks (Twitter) - Apr 9, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa 🙌🏽 (Twitter) - Apr 6, 2019
- || Vascepa (icosapent ethyl) / Amarin
The lipoprotein kinetics/pathways are critical to understand and best verbalized. Dr Peter Toth does a MASTERFUL job here. I could listen 100x; just 💚 it. Skip to his lecture if short on time. If someone listens to this, THEY KNOW what Vascepa is 💥 https://t.co/h1kR3u3pj4 (Twitter) - Apr 4, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
I'm not a doctor but from that picture it looks like Vascepa should be studied when blood flow to the brain is causing problems. Traumatic brain injury and dementia come to mind. (Twitter) - Apr 4, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Vascepa 🙌🏽 (Twitter) - Apr 4, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa to the rescue! (Twitter) - Apr 3, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
I continue to chuckle at the p value reported on this slide by @dlbhattmd (graciously blocked) on $Amrn ‘s reduceit trial data for Vascepa p= 0.00000000036 let’s assume they make a billion$. Will they report sales as $1,000,000,036? Cc : @ADAlthousePhD @f2harrell @venkmurthy (Twitter) - Apr 3, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
FDA event, Pricing: Once the FDA approves Vascepa for the new indication and it is only drug available, out of pocket/pricing/tier should get much better. (Twitter) - Apr 2, 2019
- |||| Vascepa (icosapent ethyl) / Amarin
Clinical: Anecdotally, having about 50% success getting patients Vascepa for an affordable price. Compelling, is the difference in purity of Vascepa vs. OTC Fish Oil! Data from REDUCE-IT is impressive @DLBHATTMD (Twitter) - Apr 2, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: heart valve patients don’t need vascepa (Twitter) - Apr 2, 2019
- || Vascepa (icosapent ethyl) / Amarin
@MickJagger should be put on #Vascepa after surgery! $AMRN (Twitter) - Apr 2, 2019
- || Vascepa (icosapent ethyl) / Amarin
There are hundreds of preventable events daily because people don’t know about Vascepa yet. Dr B is saving lives by helping spread the news. You do the opposite by misinforming. (Twitter) - Apr 2, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa 🙌🏽 (Twitter) - Apr 2, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: No need to pump. Vascepa will help many patients. Vascepa 🙌🏽 (Twitter) - Apr 2, 2019
- |||| Vascepa (icosapent ethyl) / Amarin
BSharma, #Vascepa saves lives, and reducing cardiovascular risks and that was the recent American Diabetes Association changed standard of care for diabetics with high triglycerides. No pumping there by Bhatt, the principal investigator for Reduce-It study. #Vascepasaveslives (Twitter) - Apr 1, 2019
- || Vascepa (icosapent ethyl) / Amarin
#Vascepa saves life, that is the reason ADA changed standard of Medical care. No pumping there (Twitter) - Apr 1, 2019
- || Vascepa (icosapent ethyl) / Amarin
This guy has been pumping Vascepa tirelessly. (Twitter) - Apr 1, 2019
- || Vascepa (icosapent ethyl) / Amarin
Fish Oil Sinks, Vascepa Rises https://t.co/1P3m3bJFpR (Twitter) - Apr 1, 2019
- ||| Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca, Vascepa (icosapent ethyl) / Amarin
Icosapent ethyl, dapagliflozin gain ground in diabetes care recommendations https://t.co/siFCVuBUJD (Twitter) - Apr 1, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa is the heart saving bomb! (Twitter) - Mar 30, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
They have to get 8 pills of that, because Omacor is a 1g capsule. The REDUCE-IT study was with higher doses (4g) so the approximate cost would be around 3000 pesos. If Vascepa costs less, I see no advantage of using Omacor. (Twitter) - Mar 30, 2019
- || Vascepa (icosapent ethyl) / Amarin
Ferrer's Omacor® have 46% of it's composition of icosapent ethyl and it's already available here in Mexico. (Twitter) - Mar 30, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa Markedly Reduces First, Repeat and Total Cardiovascular Events https://t.co/r0itL3t8If (Twitter) - Mar 30, 2019
- || Vascepa (icosapent ethyl) / Amarin
Vascepa just received priority review in Canada today. https://t.co/4TvqTgQ1zZ (Twitter) - Mar 29, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
sNDA: Vascepa sNDA Seeking Expanded Indication to Reduce Major CV Events https://t.co/nhXTlNdTmC (Twitter) - Mar 29, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Icosapent Ethyl Reduces Ischemic Event Burden in Statin-Treated Hypertriglyceridemia https://t.co/gLg9uwXops (Twitter) - Mar 29, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Canadian regulatory: HLS Therapeutics Granted Priority Review Status from Health Canada for Vascepa® https://t.co/tvTpqRlY3Z (Twitter) - Mar 29, 2019
- |||| Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca, Vascepa (icosapent ethyl) / Amarin
Clinical: Congrats @willcefalu & @AmDiabetesAssn for Living Standards of Medical Care in DM recommending icosapent ethyl for patients w/ DM & ASCVD or other CV risk REDUCED-IT & dapagliflozin treatment reducing hospitalization for HF & chronic CKD progression DECLARE #meded #hcsm (Twitter) - Mar 29, 2019
- |||| Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca, Vascepa (icosapent ethyl) / Amarin
Clinical: Congrats @willcefalu & @AmDiabetesAssn for Living Standards of Medical Care in DM recommending icosapent ethyl for patients w/ DM & ASCVD or other CV risk REDUCED-IT & dapagliflozin treatment reducing hospitalization for HF & chronic CKD progression DECLARE #meded #hcsm (Twitter) - Mar 29, 2019
- |||| Farxiga (dapagliflozin) / Ono Pharma, AstraZeneca, Vascepa (icosapent ethyl) / Amarin
Clinical: Congrats @willcefalu & @AmDiabetesAssn for Living Standards of Medical Care in DM recommending icosapent ethyl for patients w/ DM & ASCVD or other CV risk REDUCED-IT & dapagliflozin treatment reducing hospitalization for HF & chronic CKD progression DECLARE #meded #hcsm (Twitter) - Mar 29, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
NDA: 3/29 Canada accepts Vascepa NDA for review with PRIORITY REVIEW status https://t.co/2MLmrnq7Y6 (Twitter) - Mar 29, 2019
- ||| Vascepa (icosapent ethyl) / Amarin
Clinical: No Vascepa in Brazil, but I wouldn't hesitate to prescribe it, if patients fitting REDUCE-IT criteria had access to it. And let me make it clear to @DLBHATTMD as well! (Twitter) - Mar 29, 2019
- || Vascepa (icosapent ethyl) / Amarin
I wonder what EPA drug they used? If was a supplement, cant go off this trial. If purified EPA, then reassuring data for Vascepa. @DLBHATTMD (Twitter) - Mar 29, 2019